Company Analysis

MIRA Pharmaceuticals, Inc. (MIRA)

Nasdaq: MIRA · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 2022
Grade4.7
◀ Past 4.3● Present 3.7▶ Future 5.7
6 est.

Filings

140 filings since 2017 beside 58 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jul 28, 2026.

Filings a yearinsider forms included
360574830
20222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Jul 31, 2026.Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Jun 8, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Dec 20, 2024.SEC letters: 4 in the last 36 months, the newest Aug 15, 2024.
Insider forms 58

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 28, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 22, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 17, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 16, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Sep 11, 2026
Sep 1, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 31, 2026 8-K item 3.01 Listing warning from its exchange · Current report Jul 27, 2026
Jul 28, 2026 DEF 14A Proxy statement
Jul 10, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 6, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 25, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 17, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 8, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Jun 2, 2026
Jun 4, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Jun 3, 2026
May 27, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report May 21, 2026
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 13, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
May 13, 2026 8-K item 8.01 Other event · Current report May 12, 2026
Mar 31, 2026 10-K Annual report Dec 31, 2025
Mar 23, 2026 8-K item 8.01 Other event · Current report
Mar 3, 2026 8-K item 8.01 Other event · Current report
Feb 2, 2026 8-K item 8.01 Other event · Current report
Dec 22, 2025 8-K item 5.02 Officer or director change · Current report Dec 17, 2025
Dec 5, 2025 8-K items 8.01, 9.01 Other event · Current report
Dec 5, 2025 424B5 Shelf offering
Nov 13, 2025 10-Q Quarterly report Sep 30, 2025
Oct 23, 2025 8-K item 8.01 Other event · Current report
Oct 16, 2025 8-K item 8.01 Other event · Current report
Oct 15, 2025 8-K item 8.01 Other event · Current report
Sep 30, 2025 8-K items 1.01, 2.01, 3.02, 8.01, 9.01 Major agreement signed; Purchase or sale of a business completed; Shares sold without registration; Other event · Current report Sep 29, 2025
Sep 22, 2025 8-K item 8.01 Other event · Current report
Sep 15, 2025 8-K item 8.01 Other event · Current report
Sep 11, 2025 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report
Aug 19, 2025 8-K item 8.01 Other event · Current report
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Aug 12, 2025 8-K item 8.01 Other event · Current report
Aug 8, 2025 DEFM14A Merger proxy statement
Aug 8, 2025 DEFA14A Extra proxy material
Jul 29, 2025 PRER14A Form PRER14A
40 of 140 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton MIRA · research, not advice